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Asparagine-linked N-glycosylation is a common modification of proteins that promotes
productive protein folding and increases protein stability. Although N-glycosylation is
important for glycoprotein folding, the precise sites of glycosylation are often not conserved
between protein homologues. Here we show that, in Saccharomyces cerevisiae, proteins
upregulated during sporulation under nutrient deprivation have few N-glycosylation sequons
and in their place tend to contain clusters of like-charged amino-acid residues. Incorporation
of such sequences complements loss of in vivo protein function in the absence of glyco-
sylation. Targeted point mutation to create such sequence stretches at glycosylation sequons
in model glycoproteins increases in vitro protein stability and activity. A dependence on
glycosylation for protein stability or activity can therefore be rescued with a small number of
local point mutations, providing evolutionary flexibility in the precise location of N-glycans,
allowing protein expression under nutrient-limiting conditions, and improving recombinant
protein production.
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T
he presence of N-glycans assists protein folding, increases
protein solubility, reduces aggregation and limits proteo-
lysis1–5, while their specific structures affect glycoprotein
function in development, cancer, inflammation and infection3,6.
In eukaryotes, N-glycans are added to selected asparagine residues
in nascent polypeptides co- and post-translocationally in the
lumen of the endoplasmic reticulum (ER) by oligosaccharyl-
transferase (OTase)7–10. N-glycosylation by OTase occurs before
substrate protein folding, as only flexible polypeptide substrate
can bind at its active site11. The presence of Ser or Thr at the
þ 2 position markedly increases glycosylation efficiency of
asparagines, due to specific interactions with the peptide-
binding site of OTase11, and such sequences are termed glyco-
sylation sequons (N-x-S/T; xaP). Asparagines in secondary
structural elements tend to be inefficiently glycosylated12,13, as
their reduced flexibility lowers their affinity to the OTase active
site11. N-glycosylation therefore often occurs between secondary
structural elements of folded proteins14. This allows N-glycans to
optimally assist productive protein folding by their hydrophilic
bulk lowering the entropy of the protein unfolded state and acting
as nucleation sites for local folding of nascent glycopolypeptide
chains2. N-glycans can also increase protein stability by making
direct contacts with amino acids in the folded protein15,16,
increasing overall protein solubility17, shielding exposed hydro-
phobic surfaces18 and limiting proteolysis19. In the ER, N-glycans
act as signals to locally recruit ER chaperones to assist in
glycoprotein oxidative folding and are important in glycoprotein
quality control and degradation2,20–22. Although N-glycans are
important for protein folding and function, the precise sites of
glycosylation within a protein are not generally conserved in
homologues.
Here, we study the extent to which peculiar amino-acid
sequences can functionally replace N-glycosylation sites. We
show that clusters of like-charged amino acids in place of
N-glycosylation sequons can impart local protein stability and
improve protein function in the absence of glycosylation.
Results
Sequence analysis of yeast cell wall N-glycoproteins. In the
absence of a nitrogen source and in the presence of a non-
fermentable carbon source, bakers’ yeast S. cerevisiae ceases
vegetative growth and enters sporulation23. This results in large
changes to many aspects of yeast biology including remodelling of
the cell wall. Key enzymes involved in this process are the
GAS family of glucanases/transglycosidases. Gas1p is a major cell-
wall protein during vegetative growth while its functionally
equivalent paralogue Gas2p is predominantly expressed during
sporulation24,25. Gas1p and Gas2p share 45% sequence identity,
conserved secondary structure and identical disulphide bond
connectivity26,27. However, Gas1p has 10 N-glycosylation
sequons while Gas2p has only 1. This prompted us to test if
other sporulation-induced proteins also had few glycosylation
sequons. This analysis showed that glycoproteins upregulated in
sporulation did have fewer glycosylation sequons than their
paralogues expressed during vegetative growth (Fig. 1a). The
nutrient limitations that induce sporulation may provide a
selective pressure for reducing flux through the energetically
expensive N-glycosylation pathway, resulting in loss of
N-glycosylation sequons from sporulation-specific proteins.
Given the importance of N-glycosylation for protein folding,
we investigated if the equivalent positions of N-glycans in
paralogues that lacked a sequon at that particular site had
compensatory amino-acid sequences. For this, we used a set
of experimentally validated yeast glycosylation sites13,28–30.
Sequence analysis of positions in paralogues corresponding to
these sites showed that they had more acidic amino acids
compared with both validated glycosylation sites and the average
amino-acid composition of the whole protein set (Fig. 1b–d). This
enrichment was only significant in the immediate vicinity of the
residues corresponding to the location of the glycosylation sequon
(Fig. 1e–h), although the high sequence diversity in this analysis
precluded the identification of more specific patterns.
Functional complementation of glycosylation sites in yeast.
To test if these clusters of acidic amino acids served to provide
local intrinsic stability to the protein even in the absence of
N-glycosylation, we expressed and purified the model glycopro-
teins yeast Gas1p and Gas2p as secreted MBP fusions in E. coli
and S. cerevisiae. Given Gas1p has many more N-glycosylation
sequons than Gas2p, we predicted that Gas2p would be more
stable than Gas1p when expressed without N-glycosylation in
E. coli. Circular dichroism (CD) spectroscopy of E. coli-expressed
protein was consistent with MBP-Gas2 containing more helical
secondary structure than MBP-Gas1, while the native glycosy-
lated forms of these S. cerevisiae-expressed proteins showed
equivalent CD spectra (Fig. 2a,b). MS analysis of the disulphide
bond connectivity by non-reducing tryptic peptide mapping
showed that both E. coli-expressed MBP-Gas1 and MBP-Gas2
had incorrect connectivity compared with native protein
expressed in yeast (Supplementary Tables 1 and 2)26,27. To enable
comparison with native glycosylated MBP-Gas1 and MBP-Gas2,
we created disulphide shuffled forms of these S. cerevisiae-
expressed proteins. CD spectra of these disulphide shuffled forms
of MBP-Gas1 and MBP-Gas2 were similar to their native forms
(Fig. 2a,b). This is consistent with the increased stability and
secondary structure in nonglycosylated MBP-Gas2 compared
with nonglycosylated MBP-Gas1 being local effects that influence
secondary structure formation. That is, the absence of
N-glycosylation at the 10 glycosylation sites in Gas1p strongly
affected local formation of secondary structural elements, whereas
this affect was not as strong in Gas2p, which with only a single
glycosylation site does not natively rely on N-glycosylation for
stability to the extent of Gas1p.
We next tested if the Gas2p sequences corresponding to Gas1p
glycosylation sites were functionally equivalent in vivo. Yeast cells
with deletion of GAS1 showed reduced growth compared with
wild-type cells, which was complemented by overexpression
of native Gas1p (Fig. 2c). Gas1p is glycosylated at Asn40
(NN40GS)13 and expression of variant Gas1-N40Q lacking this
glycosylation site did not complement loss of GAS1 (Fig. 2c).
While Asn-Gln site-directed mutagenesis is routinely used to test
the importance of particular glycosylation sites in glycoprotein
folding and function, the conformational preferences of Gln are
very different to those of Asn, while His is more similar to Asn31.
Expression of variant Gas1-N40H only partially complemented
loss of GAS1 (Fig. 2c). This lack of complementation indicated
that glycosylation at Asn40 was required for Gas1p function
in the context of the native sequence. However, replacing this
stretch of Gas1p with the corresponding sequence from Gas2p
(39ESGE42; Supplementary Fig. 1a) restored growth, as did point
mutation to insert proximal Asp residues (Fig. 2c), while
retaining the conserved Gly41 (Supplementary Fig. 1b). The
dependency of in vivo Gas1p function on glycosylation at Asn40
could therefore be rescued by a small number of compensatory
point mutations introducing local clusters of negatively charged
residues.
Stabilization of unglycosylated human interferon-b. Animal
glycoproteins are not generally required to be expressed under
such severe nutrient limitations as during yeast sporulation.
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However, human glycoproteins are often expressed for bio-
technological purposes in bacteria that lack glycosylation systems.
Such a protein is the human glycoprotein hormone interferon-b
(IFNb)32. The single N-glycosylation site in human IFNb is
not strictly conserved in orthologues and paralogues (Fig. 3a,
Supplementary Fig. 2), and in these proteins is often replaced by
clusters of acidic amino acids similar to those observed in place of
N-glycosylation sites in yeast proteins (Fig. 1, Supplementary
Fig. 1). To test if such a sequence would increase IFNb stability in
the absence of glycosylation, we expressed and purified IFNb as
wild type and glycosylation site variant (Asn101Asp) forms from
E. coli and refolded these proteins in vitro. Guanidinium-induced
unfolding equilibria showed that at physiologically relevant pH
7.5 this point mutation increased stability (DDG0  9 kJmol 1,
Fig. 3b). In contrast, at pH 5.0 the DDG0 was negligible (Fig. 3c).
We propose that this is consistent with stabilization of the
IFNbN101D variant at pH 7.5 through reduced entropy of the
unfolded state due to charge-charge repulsion between Asp101
and Glu102 favouring a local turn or extended structure similar to
the structure of Asn101 and Glu102 in folded native IFNb18, or
stabilization of the native state33,34. At pH 5 there is a lower
probability that both these residues will be simultaneously
deprotonated (negatively charged) in a given protein molecule,
consistent with the lack of stabilization in the IFNbN101D variant.
The overall higher stability for both protein forms at pH 5.0 than
at pH 7.5 is likely due to increased distance from the predicted pI
of IFNb (B9.0). This confirmed that local clusters of negatively
charged amino acids could increase protein stability in the
absence of glycosylation in homologues of human IFNb. To
confirm that stable IFNbN101D retained native activity, we
performed a cell culture growth inhibition assay (Fig. 3d).
Stable IFNbN101D showed significantly higher specific activity
than IFNb wild type (Fig. 3d), correlating increased
thermodynamic stability with improved protein function in this
assay. This suggested that it is possible for IFN proteins to have
either N-glycosylation sites or sequence stretches that can play a
similar role in protein folding and stability.
Stabilization at an inefficiently glycosylated sequon. Aspar-
agines in sequons generally show macroheterogeneity with not all
of the protein pool glycosylated, and almost all sequons are
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Figure 1 | Equivalent sequences to glycosylation sites in yeast cell-wall proteins. (a) Glycosylation sequon density is higher in glycoprotein paralogues
upregulated in vegetative growth than in those upregulated in sporulation. Paralogues of black squares, Gas1p; white squares, Mkc7p; black circles, Exg1p;
black triangles, Plb1p; white triangles, Ecm33p; and white diamonds, Crh1p. Horizontal bars show mean for each group. *P¼0.01, 2-sided Mann–Whitney
test. (b) Weblogo representation of aligned experimentally validated glycosylation sites and (c) corresponding sequences in homologues lacking
glycosylation sites. (d) Proportion of hydrophilic, hydrophobic, acidic and basic amino acids in validated sites (black), corresponding sequences lacking
sequons (white) and in the entire protein sequences of all homologues analysed (grey). *Po0.005, Fisher’s exact test. Position specific proportion of
(e) hydrophilic, (f) hydrophobic, (g) acidic and (h) basic amino acids for validated glycosylation sites in yeast cell-wall proteins (black squares) and
corresponding sequences in paralogues lacking sites (white squares). Horizontal lines indicate mean values of the entire protein sequence of all
homologues analysed (full) and the values at which P¼0.001 by Fisher’s exact test compared with this mean for a given position (dashed).
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modified to some extent9. We therefore tested whether essentially
unmodified sequons could also be subject to sequence-based
stabilization. For this purpose we studied the paralogous yeast
proteins Ost3p and Ost6p, which are accessory subunits of
OTase7,13. The ER lumenal domain of Ost3p has a single sequon
at Asn33, which is not detectably glycosylated35 (Fig. 4a and
Supplementary Fig. 3), while Ost6p has no sequons and contains
a cluster of acidic amino acids at the position corresponding to
the Ost3p sequon (Supplementary Fig. 4). The ER lumenal
domain of Ost6p is more easily expressed than that of Ost3p in
E. coli30 and shows activity in an in vitro peptide-binding assay
when Ost3p does not36. To test if the higher in vitro activity
of Ost6p relative to Ost3p correlated with increased thermo-
dynamic stability of Ost6p, we performed guanidinium-induced
equilibrium unfolding of Ost6 and Ost3 purified from E. coli. This
showed that Ost6 (DG0¼  79±10 kJmol 1) was more stable
than Ost3 (DG0¼  28±5 kJmol 1) (Fig. 4b,f), consistent with
the presence of clusters of like-charged amino acids in place of an
unused glycosylation sequon increasing thermodynamic stability
and activity. To test this in the context of Ost6p, we introduced a
glycosylation sequon in Ost6 at the equivalent position to the
Ost3 sequon, and tested in vitro stability and peptide-binding
activity. This variant of Ost6 with a glycosylation sequon had
both reduced stability compared with wild-type Ost6 (Ost6D38N
DDG0¼ 20 kJmol 1) (Fig. 4f,g), and essentially eliminated
in vitro peptide-binding activity (Fig. 4l,m). We next tested
whether the stability and in vitro activity of Ost3 could be
increased by targeted point mutation at the unused sequon in
Ost3. We first introduced an acidic Asp in place of Asn33, which
increased stability compared with wild-type protein (Ost3N33D
DDG0¼  16 kJmol 1) (Fig. 4c), but did not result in a
detectable increase in in vitro peptide binding (Fig. 4h,i).
However, Ost3p orthologues lack sequons at this position and
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Figure 3 | Stability and activity of human IFNb variants. (a) Alignment of
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instead typically possess clusters of basic amino acids, while
Ost6p orthologues have acidic residues at this position
(Supplementary Fig. 4). This difference may depend on Ost3p-
and Ost6-specific charge distributions on a neighbouring a-helix
(Supplementary Fig. 5). We therefore tested two additional
variants with clusters of either acidic or basic like-charge.
While Ost3N33D,K34D (30KLADDSPKK38) was less stable
(DDG0¼ 6 kJmol 1) (Fig. 4d), Ost3N33K (30KLAKKSPKK38)
was more stable than Ost3N33D and wild-type Ost3
(DDG0¼  27 kJmol 1) (Fig. 4e). Optimal stabilization was
therefore achieved through minimal mutations providing a
cluster of like-charged residues. This stable Ost3N33K showed
increased in vitro binding of several peptides (Fig. 4j,k). These
peptides contained aromatic amino acids, complementary to
Phe102 in the peptide-binding groove of Ost3, a key determinant
of transient nascent polypeptide tethering by Ost3 crucial to its
function in modulating OTase activity in vivo30,36. The additional
thermodynamic stability of Ost3N33K therefore enabled its
function to be investigated in this in vitro assay.
Discussion
We show that targeted introduction of like-charged amino acids
at N-glycosylation sequons is a generally applicable technique for
increasing the stability of normally N-glycosylated proteins when
expressed from more efficient expression systems such as E. coli.
The targeted nature of this approach also limits any unanticipated
affects on protein structure or function of non-targeted
mutagenesis. The presence of a sequon rather than a compensa-
tory sequence at a specific location in a given protein may also
depend on its protein context. For example, experimental1,16 and
computational37 characterization of variants of CD2 adhesion
domain from human (which is glycosylated) and rat (which is not
glycosylated) has shown that gain of glycosylation mutations in
Rat CD2 do not immediately increase protein thermodynamic
stability. However, acquisition of two additional mutations
proximal to the newly glycosylated Asn introduces specific
glycan–protein interactions, which lead to the formation of high-
occupancy hydrogen bonds and stabilize the glycosylated protein.
Alternatively, while loss of glycosylation mutations in human
CD2 destabilizes the protein, two additional nearby mutations
rescue stability and function38. Experimentally, Asn-Gln site-
directed mutagenesis is commonly used as a proxy for loss of
glycosylation at a given site. Such a mutation may show if
glycosylation at that site is important for protein folding, stability
or activity, in the context of an otherwise unchanged protein
sequence. However, our bioinformatics, in vitro and in vivo
results here show that such a requirement could in general be
easily rescued by evolutionary acquisition of a small number of
stabilizing point mutations. The exact reasons why particular
glycoproteins have N-glycosylation sites at specific locations are
undoubtedly complex, depending not only on their affect on
global protein stability but also on evolutionary history and the
many roles of N-glycans in influencing protein function.
Methods
Sequence analyses. Families of yeast glycoproteins with members expressed
predominantly during vegetative growth or sporulation were identified from
expression data23 and UniProt BLAST with a cutoff of e-4. Sequence analysis was
performed based on a set of experimentally validated occupied glycosylation sites
in S. cerevisiae cell-wall glycoproteins (28 sites in 13 glycoproteins)13,28,29.
Homologues to these from S. cerevisiae were identified with UniProt BLAST with a
cutoff of e-4, and each of these sets of homologous proteins and glycoproteins were
aligned with ClustalW. For each experimentally validated glycosylation site, aligned
sequences of homologous proteins were identified that did not contain a
glycosylation sequon at that position (41 sequences). The characteristics of the
amino-acid sequences flanking these sites (glycosylation sites, and corresponding
sequences in homologues lacking glycosylation sites) were determined through a
non-gapped alignment visualized with WebLogo39 and amino-acid composition
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Figure 4 | Stability and function of yeast Ost3 and Ost6 variants.
(a) Alignment of Ost3 and Ost6. The Ost3 glycosylation sequon is
underlined and corresponding cluster of acidic amino acids in Ost6 are in
bold. Guanidinium induced equilibrium unfolding of (b) Ost3, (c) Ost3N33D,
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protein folding. Peptide binding to Ost3 wild type (black) and Ost3N33D
(purple) by peptides (h) LVIWINGDK (m/z of 1,057.6þ ) and
(i) FFYSNNGSQFYIR (m/z of 1,642.8þ ), to Ost3 wild type (black) and
Ost3N33K (red) by peptides (j) LVIWINGDK (m/z of 1,057.6
þ ) and
(k) FFYSNNGSQFYIR (m/z of 1,642.8þ ), and to Ost6 wild type (black)36
and Ost6D38N (blue) by (l) LVIWINGDK (m/z of 1,057.6
þ ) and
(m) AGLTFLVDLIK (m/z of 1,189.7þ ). Values show mean of triplicates,
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NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4099 ARTICLE
NATURE COMMUNICATIONS | 5:3099 |DOI: 10.1038/ncomms4099 |www.nature.com/naturecommunications 5
& 2014 Macmillan Publishers Limited. All rights reserved.
(hydrophilic, hydrophobic, acidic or basic). pI of the amino-acid sequences was
determined with ProtParam40.
Cloning and mutagenesis. DNA encoding the ER lumenal domain of S. cerevisiae
Gas2p as predicted in the UniProt Knowledgebase (position 25 to 531 of Gas2p/
Q06135/YLR343W) was cloned into the pMAL-p2x vector, using PCR primers
incorporating BamHI and HindIII restriction sites, to give pMAL-GAS2. DNA
encoding the GAS1 genomic locus (GAS1/P22146/YMR307W including 1 kb up
and downstream) was cloned into the pRS415 vector to give pRS415-GAS1. Blunt
ended DNA encoding mature MBP-Gas1 or MBP-Gas2 was amplified using PCR
primers incorporating a C-terminal His-tag, phosphorylated with T4 polynucleo-
tide kinase, and ligated into blunt ended DNA amplified from pRS415-GAS1
excluding DNA encoding mature GAS1 (ref. 41). This produced pRS415-MBP-
GAS1-His and pRS415-MBP-GAS2-His, which encoded MBP-Gas1-His or MBP-
Gas2-His with the native Gas1p signal sequence under the control of the native
GAS1 promoter and terminator. DNA encoding the mature protein sequence of
IFNb as predicted in the UniProt Knowledgebase (position 22 to 187 of P01574)
with Cys17 changed to Ser32 and with an N-terminal decaHis-tag, optimized for
E. coli protein expression was synthesized and cloned into the pJexpress404
expression vector (DNA 2.0). DNA sequence encoding a C-terminal FLAG-tag was
inserted in S. cerevisiae OST3 on plasmid YEp352 (ref. 42) using site-directed
mutagenesis41 to create pOST3-FLAG. Point mutation of GAS1, IFNb and OST3
were performed by site-directed mutagenesis41.
Cell culture and protein purification. BY4741 (MATa his3D1 leu2D0 met15D0
ura3D0) yeast cells and the Dgas1 mutant derivative thereof (Open Biosystems) was
transformed with pRS415, pRS415-GAS1 or variants using standard protocols.
Cells were diluted to equal densities at OD600 nm, serially 10-fold diluted, equal
volumes spotted to minimal media agar plates and incubated at 30oC. TOP10
E. coli cells carrying the plasmids encoding IFNb, Ost6 (pHis10-OST6L43), Ost3
(pHis10-OST3L43) or variants thereof were grown in LB media, and cells carrying
pMAL-Gas1 (ref. 36) or pMAL-Gas2 were grown in LB-glucose media. Media was
supplemented with 100mg l 1 ampicillin. Protein expression was induced by
addition of IPTG to 1mM at an OD600 nm of 0.7. After incubation for 4 h at 37 C
the cells were collected by centrifugation. MBP-Gas1 and MBP-Gas2 were purified
as previously described36, except that protein was eluted with 10mM maltose.
Yeast cells carrying pRS415-MBP-GAS1-His or pRS415-MBP-GAS2-His were
grown in minimal media at 30 C with shaking and collected at an OD600 nm
of 1.0. Cells were resuspended in 50mM phosphate buffer pH 7.5, 150mM NaCl,
1 protease inhibitor cocktail (Roche) and 1mM PMSF, and lysed by French
Press. Proteins were purified using TALON resin (Clontech) and eluted in 50mM
phosphate buffer pH 7.5, 150mM NaCl and 250mM imidazole. The TALON resin
eluate was then applied to amylose-agarose beads and purified as previously
described36, except that protein was eluted with 10mM maltose. Disulphide-
shuffled protein was produced by reduction in 6M guanidinium chloride, 50mM
phosphate buffer pH 7.5 with 10mM DTT, buffer exchange into 1M guanidinium
chloride, 50mM phosphate buffer pH 7.5 with 0.1mM CuSO4 and incubation at
25 C for 2 h. Protein was then buffer exchanged into 20mM phosphate buffer pH
7.5, 200mM NaCl and 1mM EDTA. Collected cells expressing IFNb variants were
resuspended in 50mM phosphate buffer pH 7.5, 150mM NaCl, 1 protease
inhibitor cocktail (Roche) and 1mM PMSF, and lysed by French Press. Inclusion
bodies were recovered by sequential centrifugation at 18,000 rcf. The pellets were
washed with 1ml 50mM phosphate buffer pH 7.5 and 150mM NaCl and
re-centrifuged three times. The washed pellets containing inclusion bodies were
resolublized in 6M guanidinium chloride, 50mM phosphate buffer pH 7.5 and
1mM b-mercaptoethanol and incubated at 37 C for 16 h. His-tagged IFNb was
purified using TALON resin (Clontech) and eluted in 6M guanidinium chloride,
50mM phosphate buffer pH 5.0 and 1mM b-mercaptoethanol. The pH was
adjusted to pH 7.5 with other constituents remaining constant, DTT was added to
20mM and the protein was incubated at 37 C for 1 h. Protein was buffer
exchanged with PD-10 columns (GE Healthcare) into 50mM phosphate buffer pH
7.5 and 6M guanidinium chloride. Cysteines were oxidized to cystine by addition
of 0.1mM CuSO4 and incubation at 25 C for 2 h. Oxidation was quenched by
addition of 1mM EDTA, and oxidized IFNb was buffer exchanged with PD-10
columns into 50mM phosphate buffer pH 7.5 and 25% glycerol at 4 C. Cells
expressing N-terminally His-tagged Ost6, Ost3 or variants thereof were
resuspended in ice cold 50mM Potassium Phosphate, pH 7.5, 150mM NaCl,
10mM Imidazole, 1 complete mini EDTA free protease inhibitor (Roche) and
1mM PMSF, and lysed by French Press. Protein was purified from clarified whole-
cell extract using TALON resin and eluted with 200mM imidazole. Proteins were
buffer exchanged with PD-10 columns into 50mM potassium phosphate buffer pH
7.0 and 1mM EDTA. Yeast with pOST3 or pOST3-FLAG were grown in minimal
media at 30 C and collected at mid log phase. Proteins were denatured in SDS
sample buffer, incubated for 1 h at 37 C with 1G5 buffer in the presence or
absence of Endo H13, separated by SDS-PAGE, transferred to nitrocellulose
membrane and probed with an a-FLAG antibody.
In vitro protein analysis. CD spectra were obtained using a Jasco J-710
spectrometer (Jasco, Japan) as described44. Free energies of stabilization (DG0)
were determined based on the two-state model of protein folding45 as described30.
To determine the equilibrium transitions, intrinsic tryptophan fluorescence of
proteins was measured in different concentrations of guanidinium chloride in
50mM potassium phosphate pH 7.5 or 5.0, and 150mM NaCl at 25 C. DG0 and
cooperativity were determined from a non-linear least-squares 6 parameter fit to
the data points45, with uncertainty estimates from the corresponding six-parameter
fits. Ost3 and Ost6 peptide-binding affinity chromatography was performed as
described36. Briefly, tryptic peptides from MBP-Gas1p were applied to peptide-
affinity chromatography columns containing MBP-Ost3, MBP-Ost3N33K,
MBP-Ost6 or MBP-Ost6D38N bound to amylose-agarose resin with or without
pre-reduction with DTT. Peptides were eluted with physiological buffer, fractions
collected, and peptides in the load and elution fractions were detected with
MALDI-TOF-MS. Peptide retention was determined by the relative abundance of
each peptide in wash fractions compared with the load, in oxidized relative to
reduced. Reduction of the CxxC motif in Ost6p causes structural changes only at
the peptide-binding groove30, confirming that retained peptides bind at this groove
rather than through other non-specific interactions36.
Cell culture growth inhibition assay. A total of 4 103 Human MCF-7 breast
tumour cells were cultured in 200 ml of phenol-free media containing 5% charcoal
stripped calf serum in 96-well plates. Equal amounts of either human recombinant
IFNb (ProSpec CYT-234), IFN-bWT, IFN-bN101D or no protein were added to the
cultures with retinoic acid (Sigma) and incubated for 4 days as described46. Cells
were fixed with a final concentration of 3.3% (wt/vol) TCA and stained with
Sulforhodamine B (Sigma R2625) as described47, after which the OD was measured
at 490 nm. A control plate to determine initial seeding intensity was included where
cells were fixed 2–3 h after plating. Absorbance with this plate was set as 0%
growth, and growth obtained with untreated cells was taken as 100%.
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